Neuropace, Inc. NPCE EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s EBIT?
- Neuropace, Inc. (NPCE) reported EBIT of -$5.57M in Q1 2026.
- How has Neuropace, Inc.'s EBIT changed year-over-year?
- Neuropace, Inc.'s EBIT decreased by 8.2% year-over-year, from -$5.15M to -$5.57M.
- What is the long-term trend for Neuropace, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s EBIT has grown at a -8.9% compound annual growth rate (CAGR), from -$23.74M to -$16.34M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.